ALBIREO PHARMA, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2010 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Albireo Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q1 2022.
- Albireo Pharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$35.4M, a 2% decline year-over-year.
- Albireo Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$108M, a 6.46% decline from 2020.
- Albireo Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$101M, a 90.9% decline from 2019.
- Albireo Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2019 was -$52.9M, a 97.4% decline from 2018.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)